Equities

iRay Technology Co Ltd

688301:SHH

iRay Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)112.93
  • Today's Change-4.07 / -3.48%
  • Shares traded1.13m
  • 1 Year change-31.20%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

iRay Technology Company Limited is a China-based company principally engaged in the research and development, production and sales of digital X-ray detectors, as well as the provision of related services. The Company's products include universal radio frequency series, universal radio frequency series, breast series and radiotherapy series. The Company's products are applied in medical diagnosis and treatment, industrial non-destructive testing and security inspection fields. The Company distributes its products within domestic market and to overseas markets.

  • Revenue in CNY (TTM)1.82bn
  • Net income in CNY564.72m
  • Incorporated2011
  • Employees1.66k
  • Location
    iRay Technology Co LtdBuilding 45No. 1000 Jinhai Road, Pudong New AreaSHANGHAI 201206ChinaCHN
  • Phone+86 2 150720560
  • Fax+86 2 150720561
  • Websitehttp://www.iraygroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.27bn657.34m13.42bn908.0020.013.45--10.585.445.4410.5931.540.3711.336.511,396,816.0019.0017.6821.5519.4374.5176.6051.2142.255.49--0.006744.4632.4338.7237.9840.2850.18--
Micro-Tech Nanjing Co Ltd2.68bn550.49m13.96bn2.40k25.283.74--5.212.942.9414.3019.860.61181.656.801,114,222.0012.8710.7415.2612.8266.0463.0421.0419.373.99--0.018335.4321.7821.2046.9920.3239.33--
Shanghai Haohai Biological Tech Co Ltd2.75bn430.21m13.98bn2.16k35.732.76--5.091.861.8611.8924.070.38331.607.601,272,966.005.604.846.605.5068.9772.0414.6116.363.71--0.069736.8624.5911.24130.580.076211.96--
Sansure Biotech Inc1.41bn259.42m14.05bn2.01k53.921.91--9.990.44750.44752.4412.620.16670.8782.03701,473.702.5226.742.7930.9776.4367.4715.1242.017.45--0.058322.40-84.3927.12-81.22121.8964.08--
iRay Technology Co Ltd1.82bn564.72m16.71bn1.66k31.273.64--9.163.743.7412.1432.150.25441.032.561,097,588.007.8112.078.4813.8653.9255.5930.7134.514.23--0.397231.5220.3133.51-5.2758.58107.96--
Beijing Balance Medical Technolgy Co Ltd405.57m103.55m16.79bn473.00162.2514.33--41.390.75310.75312.968.530.31831.094.94857,444.607.148.067.468.4088.3189.4122.4230.028.22--0.009169.1925.5727.3521.0928.10125.94--
Eyebright Medical Tchnlgy Beijing Co Ltd1.36bn369.60m17.66bn2.07k47.717.58--13.001.951.957.1712.290.45992.404.64654,939.8011.739.9913.2911.1665.5881.2925.5034.663.7641.180.190419.9164.1449.5930.6371.8038.83--
MGI Tech Co Ltd2.58bn-873.08m20.75bn2.87k--2.59--8.05-2.12-2.126.2619.210.24670.77452.87898,663.20-8.40---9.62--59.99---34.04--3.99--0.0766---31.19---129.98------
Data as of Nov 21 2024. Currency figures normalised to iRay Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

17.03%Per cent of shares held by top holders
HolderShares% Held
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 20247.99m5.60%
China Asset Management Co., Ltd.as of 30 Jun 20245.99m4.20%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 20242.36m1.66%
DSM Capital Partners LLCas of 31 Mar 20241.76m1.24%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20241.27m0.89%
GF Fund Management Co., Ltd.as of 30 Jun 20241.26m0.89%
China Universal Asset Management Co., Ltd.as of 30 Jun 20241.07m0.75%
China Southern Asset Management Co., Ltd.as of 30 Jun 2024916.21k0.64%
Schroder Investment Management (Hong Kong) Ltd.as of 30 Sep 2024872.03k0.61%
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024798.25k0.56%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.